Please enable JavaScript to continue using this application.

Compare $BCAX vs $ORIC | Chartloom

Compare

$BCAX vs $ORIC

Bicara Therapeutics Inc · Oric Pharmaceuticals Inc

BCAX

Bicara Therapeutics Inc

ORIC

Oric Pharmaceuticals Inc

Compare $BCAX vs $ORIC

Comparing Bicara Therapeutics Inc and Oric Pharmaceuticals Inc

BCAXBicara Therapeutics Inc

ORICOric Pharmaceuticals Inc

BCAXBicara Therapeutics Inc

Market cap

$1.15B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.8%

52W performance

-2.8%

FCF yield

-11.8%

ORICOric Pharmaceuticals Inc

Market cap

$1.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

46.8%

52W performance

-16.0%

FCF yield

-9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAX

ORIC

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

ORIC

Oric Pharmaceuticals Inc

Market Cap

BCAX$1.15B

ORIC$1.24B

Enterprise Value

BCAX$1.05B

ORIC$1.20B

Price

BCAX$17.50

ORIC$11.99

P/E Ratio

BCAXN/A

ORICN/A

P/S Ratio

BCAX0.00x

ORIC0.00x

EV/Sales

BCAX0.00x

ORIC0.00x

EV/EBITDA

BCAX0.00x

ORIC0.00x

P/B Ratio

BCAX2.49x

ORIC3.32x

P/FCF Ratio

BCAXN/A

ORICN/A

EV/FCF

BCAX-7.79x

ORIC-10.72x

PEG Ratio

BCAXN/A

ORICN/A

Forward P/E (NTM)

BCAXN/A

ORICN/A

Forward P/S (NTM)

BCAXN/A

ORICN/A

Revenue (TTM)

BCAX$0

ORIC$0

Revenue Growth (YoY)

BCAXN/A

ORICN/A

Forward Rev Growth

BCAX1358.6%

ORIC1520.7%

Gross Margin (TTM)

BCAX0.0%

ORIC0.0%

Operating Margin (TTM)

BCAX0.0%

ORIC0.0%

EBITDA Margin (TTM)

BCAX0.0%

ORIC0.0%

Net Margin (TTM)

BCAX0.0%

ORIC0.0%

FCF Margin (TTM)

BCAXN/A

ORICN/A

Net Income (TTM)

BCAX$-185M

ORIC$-140M

FCF (TTM)

BCAX$-135M

ORIC$-112M

EPS (TTM)

BCAX-$2.73

ORIC-$1.30

ROE (TTM)

BCAX-4149.0%

ORIC-3535.0%

ROA (TTM)

BCAX-3859.0%

ORIC-3339.0%

ROIC (TTM)

BCAX-4149.0%

ORIC-3535.0%

Cash

BCAX$97M

ORIC$37M

Debt

BCAX$0

ORIC$0

Net Cash/Debt

BCAX$97M

ORIC$37M

Current Ratio (TTM)

BCAX11.59x

ORIC13.19x

Quick Ratio (TTM)

BCAX11.44x

ORIC12.76x

Debt/Equity (TTM)

BCAX0.00x

ORIC0.00x

Debt/Assets (TTM)

BCAX0.0%

ORIC0.0%

Interest Coverage (TTM)

BCAXN/A

ORICN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

ORIC0.00x

Beta

BCAX0.94

ORIC1.13

52W Performance

BCAX-2.8%

ORIC-16.0%

YTD Performance

BCAX6.8%

ORIC46.8%

% from 52W High

BCAX-43.5%

ORIC-18.3%

% from 52W Low

BCAX27.7%

ORIC65.8%

Asset Turnover (TTM)

BCAX0.00x

ORIC0.00x

FCF Yield (TTM)

BCAX-11.8%

ORIC-9.0%

Earnings Yield (TTM)

BCAX-16.1%

ORIC-11.3%

Dividend Yield (TTM)

BCAXN/A

ORICN/A

Rule of 40

BCAX0.0

ORIC0.0

EV/GP/RG

BCAXN/A

ORICN/A

Ticker research

View BCAX research View ORIC research

Metric	BCAX Bicara Therapeutics Inc	ORIC Oric Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.15B	$1.24B
Enterprise Value	$1.05B	$1.20B
Price	$17.50	$11.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	3.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-10.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	1520.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-140M
FCF (TTM)	$-135M	$-112M
EPS (TTM)	-$2.73	-$1.30
ROE (TTM)	-4149.0%	-3535.0%
ROA (TTM)	-3859.0%	-3339.0%
ROIC (TTM)	-4149.0%	-3535.0%
Financial Health
Cash	$97M	$37M
Debt	$0	$0
Net Cash/Debt	$97M	$37M
Current Ratio (TTM)	11.59x	13.19x
Quick Ratio (TTM)	11.44x	12.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.13
52W Performance	-2.8%	-16.0%
YTD Performance	6.8%	46.8%
% from 52W High	-43.5%	-18.3%
% from 52W Low	27.7%	65.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-9.0%
Earnings Yield (TTM)	-16.1%	-11.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View ORIC research

Valuation

P/S Ratio

BCAX

0.00x

ORIC

0.00x

EV/FCF

ORIC

-10.72x

BCAX

-7.79x

Growth & revenue

Forward Revenue Growth

ORIC

1520.7%

BCAX

1358.6%

Profitability & performance

Gross Margin

BCAX

0.0%

ORIC

0.0%

ROE

ORIC

-3535.0%

BCAX

-4149.0%

FCF Yield %

ORIC

-9.0%

BCAX

-11.8%

52-Week Performance

BCAX

-2.8%

ORIC

-16.0%

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

ORIC

Oric Pharmaceuticals Inc

Market Cap

BCAX$1.15B

ORIC$1.24B

Enterprise Value

BCAX$1.05B

ORIC$1.20B

Price

BCAX$17.50

ORIC$11.99

P/E Ratio

BCAXN/A

ORICN/A

P/S Ratio

BCAX0.00x

ORIC0.00x

EV/Sales

BCAX0.00x

ORIC0.00x

EV/EBITDA

BCAX0.00x

ORIC0.00x

P/B Ratio

BCAX2.49x

ORIC3.32x

P/FCF Ratio

BCAXN/A

ORICN/A

EV/FCF

BCAX-7.79x

ORIC-10.72x

PEG Ratio

BCAXN/A

ORICN/A

Forward P/E (NTM)

BCAXN/A

ORICN/A

Forward P/S (NTM)

BCAXN/A

ORICN/A

Revenue (TTM)

BCAX$0

ORIC$0

Revenue Growth (YoY)

BCAXN/A

ORICN/A

Forward Rev Growth

BCAX1358.6%

ORIC1520.7%

Gross Margin (TTM)

BCAX0.0%

ORIC0.0%

Operating Margin (TTM)

BCAX0.0%

ORIC0.0%

EBITDA Margin (TTM)

BCAX0.0%

ORIC0.0%

Net Margin (TTM)

BCAX0.0%

ORIC0.0%

FCF Margin (TTM)

BCAXN/A

ORICN/A

Net Income (TTM)

BCAX$-185M

ORIC$-140M

FCF (TTM)

BCAX$-135M

ORIC$-112M

EPS (TTM)

BCAX-$2.73

ORIC-$1.30

ROE (TTM)

BCAX-4149.0%

ORIC-3535.0%

ROA (TTM)

BCAX-3859.0%

ORIC-3339.0%

ROIC (TTM)

BCAX-4149.0%

ORIC-3535.0%

Cash

BCAX$97M

ORIC$37M

Debt

BCAX$0

ORIC$0

Net Cash/Debt

BCAX$97M

ORIC$37M

Current Ratio (TTM)

BCAX11.59x

ORIC13.19x

Quick Ratio (TTM)

BCAX11.44x

ORIC12.76x

Debt/Equity (TTM)

BCAX0.00x

ORIC0.00x

Debt/Assets (TTM)

BCAX0.0%

ORIC0.0%

Interest Coverage (TTM)

BCAXN/A

ORICN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

ORIC0.00x

Beta

BCAX0.94

ORIC1.13

52W Performance

BCAX-2.8%

ORIC-16.0%

YTD Performance

BCAX6.8%

ORIC46.8%

% from 52W High

BCAX-43.5%

ORIC-18.3%

% from 52W Low

BCAX27.7%

ORIC65.8%

Asset Turnover (TTM)

BCAX0.00x

ORIC0.00x

FCF Yield (TTM)

BCAX-11.8%

ORIC-9.0%

Earnings Yield (TTM)

BCAX-16.1%

ORIC-11.3%

Dividend Yield (TTM)

BCAXN/A

ORICN/A

Rule of 40

BCAX0.0

ORIC0.0

EV/GP/RG

BCAXN/A

ORICN/A

Ticker research

View BCAX research View ORIC research

Metric	BCAX Bicara Therapeutics Inc	ORIC Oric Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.15B	$1.24B
Enterprise Value	$1.05B	$1.20B
Price	$17.50	$11.99
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	3.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	-10.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	1520.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-140M
FCF (TTM)	$-135M	$-112M
EPS (TTM)	-$2.73	-$1.30
ROE (TTM)	-4149.0%	-3535.0%
ROA (TTM)	-3859.0%	-3339.0%
ROIC (TTM)	-4149.0%	-3535.0%
Financial Health
Cash	$97M	$37M
Debt	$0	$0
Net Cash/Debt	$97M	$37M
Current Ratio (TTM)	11.59x	13.19x
Quick Ratio (TTM)	11.44x	12.76x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.13
52W Performance	-2.8%	-16.0%
YTD Performance	6.8%	46.8%
% from 52W High	-43.5%	-18.3%
% from 52W Low	27.7%	65.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	-9.0%
Earnings Yield (TTM)	-16.1%	-11.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View ORIC research